Nikko Asset Management Americas, Inc. Cerus Corp Transaction History

Nikko Asset Management Americas, Inc.

$9.23 Billion
Q3 2025

A detailed history of Nikko Asset Management Americas, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 5,685,177 shares of CERS stock, worth $9.21 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,685,177

Previous 6,062,129 6.22%

Holding current value

$9.21 Million

Previous $8.55 Million 5.76%

% of portfolio

0.1%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$1.16 - $1.6 $437,264 - $603,123	-376,952 Reduced 6.22%	5,685,177 $9.04 Million
Q2 2025 Aug 11, 2025	SELL	$1.22 - $1.51 $157,087 - $194,427	-128,760 Reduced 2.08%	6,062,129 $8.55 Million
Q1 2025 May 07, 2025	SELL	$1.39 - $2.15 $376,405 - $582,209	-270,795 Reduced 4.19%	6,190,889 $8.61 Million
Q4 2024 Feb 10, 2025	SELL	$1.52 - $2.03 $879,476 - $1.17 Million	-578,603 Reduced 8.22%	6,461,684 $9.95 Million
Q3 2024 Nov 07, 2024	SELL	$1.7 - $2.39 $778,520 - $1.09 Million	-457,953 Reduced 6.11%	7,040,287 $12.3 Million

Q2 2024 Aug 09, 2024	SELL	$1.62 - $2.04 $408,985 - $515,018	-252,460 Reduced 3.26%	7,498,240 $13.2 Million
Q1 2024 May 02, 2024	BUY	$1.66 - $2.42 $303,164 - $441,962	182,629 Added 2.41%	7,750,700 $14.6 Million
Q4 2023 Feb 08, 2024	SELL	$1.25 - $2.35 $430,838 - $809,976	-344,671 Reduced 4.36%	7,568,071 $16.3 Million
Q3 2023 Nov 09, 2023	SELL	$1.5 - $3.07 $485,623 - $993,909	-323,749 Reduced 3.93%	7,912,742 $12.8 Million
Q2 2023 Aug 14, 2023	BUY	$1.79 - $2.9 $392,298 - $635,566	219,161 Added 2.73%	8,236,491 $20.3 Million
Q1 2023 May 03, 2023	BUY	$2.65 - $3.81 $2.24 Million - $3.22 Million	846,050 Added 11.8%	8,017,330 $23.8 Million
Q4 2022 Feb 13, 2023	SELL	$3.38 - $4.22 $543,297 - $678,318	-160,739 Reduced 2.19%	7,171,280 $26.2 Million
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.83 $10.1 Million - $17.2 Million	-2,955,332 Reduced 28.73%	7,332,019 $25.7 Million
Q2 2022 Aug 04, 2022	SELL	$4.41 - $5.69 $1.54 Million - $1.99 Million	-349,955 Reduced 3.29%	10,287,351 $52.8 Million
Q1 2022 May 06, 2022	SELL	$4.81 - $6.99 $4.29 Million - $6.24 Million	-892,410 Reduced 7.74%	10,637,306 $48.9 Million
Q4 2021 Feb 08, 2022	SELL	$5.97 - $7.93 $4.54 Million - $6.03 Million	-760,820 Reduced 6.19%	11,529,716 $77.4 Million
Q3 2021 Nov 09, 2021	SELL	$4.79 - $6.68 $4.12 Million - $5.75 Million	-860,572 Reduced 6.54%	12,290,536 $75.6 Million
Q2 2021 Aug 09, 2021	SELL	$5.35 - $6.35 $1.3 Million - $1.54 Million	-243,147 Reduced 1.82%	13,151,108 $77.7 Million
Q1 2021 May 03, 2021	BUY	$5.68 - $7.87 $13 Million - $18 Million	2,291,045 Added 20.63%	13,394,255 $80.5 Million
Q4 2020 Feb 11, 2021	BUY	$5.25 - $8.56 $7.36 Million - $12 Million	1,402,054 Added 14.45%	11,103,210 $76.8 Million
Q3 2020 Nov 02, 2020	SELL	$5.78 - $7.47 $5.76 Million - $7.44 Million	-996,046 Reduced 9.31%	9,701,156 $61 Million
Q2 2020 Aug 07, 2020	SELL	$4.5 - $7.02 $55,615 - $86,760	-12,359 Reduced 0.12%	10,697,202 $67.2 Million
Q1 2020 Apr 30, 2020	BUY	$2.87 - $5.49 $2.71 Million - $5.19 Million	944,507 Added 9.67%	10,709,561 $49.8 Million
Q4 2019 Feb 06, 2020	BUY	$3.84 - $4.86 $4.69 Million - $5.93 Million	1,220,778 Added 14.29%	9,765,054 $41.2 Million
Q3 2019 Oct 29, 2019	BUY	$4.86 - $6.05 $17 Million - $21.1 Million	3,494,891 Added 69.21%	8,544,276 $44 Million
Q2 2019 Jul 29, 2019	BUY	$4.51 - $6.6 $18.5 Million - $27.1 Million	4,103,996 Added 434.11%	5,049,385 $28.4 Million
Q1 2019 Apr 30, 2019	BUY	$5.16 - $6.85 $4.85 Million - $6.43 Million	939,372 Added 15611.97%	945,389 $5.89 Million
Q4 2018 Feb 08, 2019	SELL	$4.89 - $7.16 $547 - $801	-112 Reduced 1.83%	6,017 $31,000
Q3 2018 Oct 15, 2018	BUY	$6.89 - $7.78 $42,228 - $47,683	6,129 New	6,129 $44,000

Others Institutions Holding CERS

# of Institutions

166

Shares Held

135M

Call Options Held

126K

Put Options Held

30.1K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $287M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account

Nikko Asset Management Americas, Inc. Cerus Corp Transaction History